Computed tomography in staging for lung cancer

European Respiratory Journal, Supplement

Volumn 19, Issue 35, 2002, Pages

  Verschakelen, Johny A ^a   Bogaert, J ^a   De Wever, W ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Computed tomography; Lung neoplasms; Staging

Indexed keywords

CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; INFORMATION PROCESSING; LUNG CANCER; LYMPH NODE METASTASIS; MEDICAL EXAMINATION; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; CANCER INVASION; LUNG TUMOR; LYMPH NODE; PATHOLOGY; RADIOGRAPHY; REVIEW; THORAX RADIOGRAPHY;

HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOGRAPHY, THORACIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036481424     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (98)

1. Evens RG. New frontier for radiology: computed tomography. 40th Annual Preston M. Hickey Memorial Lecture. Am J Roentgenol 1976; 126: 1117-1129.
2. Maravilla KR, Pastel MS. Technical aspects of CT scanning. Comput Tomogr 1978; 2: 137-144.
3. TerPogossian MM. Basic principles of computed axial tomography. Semin Nucl Med 1977; 7: 109-127.
4. Kalender WA, Seissler W, Vock P. Single-breath-hold spiral volumetric CT by continuous patient translation and scanner rotation. Radiology 1989; 173: 414.
5. Kalender WA, Polacin A, Süss C. A comparison of conventional and spiral CT: an experimental study on detection of spherical lesions. J Comput Assist Tomogr 1994; 18: 167-176.
6. Schoepf UJ, Becker C, Bruning R, et al. Computed tomography of the abdomen with multidetector-array CT. Radiologe 1999; 39: 652-661.
7. Berland LL, Smith JK. Multidetector array CT: one again, technology creates new opportunities. Radiology 1998; 209: 327-329.
8. Uffmann M, Prokop M. Multislice CT of the lung. Technique and clinical applications. Radiologe 2001; 41: 240-247.
9. Meziane MA, Hruban RH, Zerhouni EA, et al. High resolution CT of the lung parenchyma with pathologic correlation. Radiographics 1988; 8: 27-54.
10. Murata K, Khan A, Rojas KA, Herman PG. Optimization of computed tomography technique to demonstrate the fine structure of the lung. Invest Radiol 1988; 23: 170-175.
11. Schaefer-Prokop C, Prokop M. New imaging techniques in the treatment guidelines for lung cancer. Eur Respir J 2002; 19: Suppl. 35, 71s-83s.
12. Primack SL, Lee KS, Logan PM, Miller RR, Müller NL. Bronchogenic carcinoma: utility of CT in the evaluation of patients with suspected lesions. Radiology 1994; 193: 795-800.
13. Lahde S, Paivansalo M, Rainio P. CT for predicting the resectability of lung cancer: a prospective study. Acta Radiol 1991; 32: 449-454.
14. Lewis JW, Madrazo BL, Gross SC. The value of radiographic and computed tomography in the staging of lung carcinoma. Ann Thorac Surg 1982; 34: 553-558.
15. Lewis JW, Pearlberg JL, Beute GH, et al. Can computed tomography of the chest stage lung cancer? Yes and no. Ann Thorac Surg 1990; 49: 591-596.
16. Kesler KA, Conces DJ, Heimansohn DA, Mathur P. Assessing the feasibility of bronchoplastic surgery with magnetic resonance imaging. Ann Thorac Surg 1991; 52: 145-147.
17. Mayr B, Lenhard M, Fink U, Heywang-Köbrunner SH, Sunder-Plasman L, Permanetter W. Preoperative evaluation of bronchogenic carcinoma: value of MR in T- and N-staging. Eur J Radiol 1992; 14: 245-251.
18. Herman SJ, Winton TL, Weisbrod GL, Tower MJ, Mentzer SJ. Mediastinal invasion by bronchogenic carcinoma: CT signs. Radiology 1994; 190: 841-846.
19. Glazer HS, Kaiser LR, Anderson DJ, et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. Radiology 1989; 173: 37-42.
20. McLoud TC. CT of bronchogenic carcinoma: indeterminate mediastinal invasion. Radiology 1989; 173: 15-16.
21. Izbicki J, Thetter O, Karg O. Accuracy of computed tomographic scan and surgical assessment for staging of bronchial carcinoma. J Thorac Cardiovasc Surg 1992; 104: 413-420.
22. Allen MS, Mathisen DJ, Grillo HC, Wain JC, Moncure AC, Hilgenberg AD. Bronchogenic carcinoma with chest wall invasion. Ann Thorac Surg 1991; 51: 948-951.
23. McCaughan BC, Martini N, Bains MS, McCormack PM. Chest wall invasion in carcinoma of the lung: therapeutic and prognostic implications. J Thorac Cardiovasc Surg 1985; 89: 836-841.
24. Pearlberg JL, Sandler MA, Beute GH, Lewis JW, Madrazo BL. Limitations of CT in evaluation of neosplasms involving chest wall. J Comput Assist Tomogr 1987; 11: 290-293.
25. Pennes DR, Glazer GM, Wimbish KJ, Gross BH, Long RW, Orringer MB. Chest wall invasion by lung cancer: limitations of CT evaluation. Am J Roentgenol 1985; 144: 507-511.
26. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the radiologic diagnostic oncology group. Radiology 1991; 148: 705-713.
27. Epstein DM, Stephenson LW, Gefter WB, van der Voorde F, Aronchik JM, Miller WT. Value of CT in the preoperative assessment of lung cancer: a survey of thoracic surgeons. Radiology 1986; 161: 423-427.
28. Grenier P, Dubray B, Carette MF, Frija G, Musset D, Chastang C. Preoperative thoracic staging of lung cancer: CT and MR evaluation. Diagn Intervent Radiol 1989; 1: 23-28.
29. Gdeedo A, VanSchil P, Corthouts B, VanMieghem F, VanMeerbeeck J, VanMarck E. Comparison of imaging TNM ((i)TNM) and pathological TNM ((p)TNM) in staging of bronchogenic carcinoma. Eur J Cardiothorac Surg 1997; 12: 224-227.
30. Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991; 51: 182-188.
31. Scott IR, Muller NL, Miller RR, Evans KG, Nelems B. Resectable Stage III lung cancer: CT, surgical and pathologic correlation. Radiology 1988; 166: 75-79.
32. Shirakawa T, Fukuda K, Miyamoto Y, Tanabe H, Tada S. Parietal pleural invasion of lung masses: evaluation with CT performed during deep inspiration and expiration. Radiology 1994; 192: 809-811.
33. Watanabe A, Shimokata K, Saka H, Nomura F, Sakai S. Chest CT combined with artificial pneumothorax: value in determining origin and extent of tumor. AJR 1991; 156: 707-710.
34. Yokoi K, Mori K, Miyazawa N, Saito Y, Okuyama A, Sasagawa M. Tumor invasion of the chest wall and mediastinum in lung cancer: evaluation with pneumothorax CT. Radiology 1991; 181: 147-152.
35. Uhrmeister P, Allmann KH, Wertzel H, et al. Chest wall infiltration by lung cancer: value of thin-sectional CT with different reconstruction algorithms. Eur Radiol 1999; 9: 1304-1309.
36. Kuriyama K, Hosomi N, Sawai Y, et al. Three-dimensional imaging of focal lung disease using spiral volumetric CT. Jpn J Clin Radiol 1994; 39: 9-13.
37. Kuriyama K, Tateishi R, Kumatani T, et al. Pleural invasion of peripheral bronchogenic carcinoma: assessment with three-dimensional helical CT. Radiology 1994; 191: 365-369.
38. LoCicero J, Costello R, Campos CT, et al. Spiral CT with multiplanar and three-dimensional reconstructions accurately predicts tracheobronchial pathology. Ann Thorac Surg 1996; 62: 811-817.
39. Lorensen WE, Jolesz FA, Kikinis R. The exploration of cross-sectional data with a virtual endoscope. In: Morgan K, Satava RM, Sieburg HB, Mattheus R, Christensen JP, eds. Interactive Technology and the New Paradigm for Healthcare. Ohmsha, IOS Press, 1995; pp. 221-230.
40. Kim Y, Soo Lee K, Yoon JH, et al. Tuberculosis of the trachea and main bronchi: CT findings in 17 patients. AJR 1997; 168: 1051-1056.
41. Remy J, Remy-Jardin M, Artaud D, Fribourg M. Multiplanar and three-dimensional reconstruction techniques in CT: impact on chest diseases. Eur Radiol 1998; 8: 335-351.
42. Hawkes DJ, Ruff CF, Studholme C, Edwards PJ, Wong WL, Padhani A. Three-dimensional multimodal imaging in image-guided interventions. Sem Intervent Radiol 1995; 12: 63-74.
43. Thompson BH, Stanford W. MR imaging of pulmonary and mediastinal malignancies. Magn Reson Imaging Clin N Am 2000; 8: 729-739.
44. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986; 160: 607-611.
45. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology 1993; 187: 33-38.
46. Castagno A, Shuman W. MR imaging in clinically suspected brachial plexus tumor. AJR 1987; 149: 1219-1222.
47. Takasugi J, Rapoport S, Shaw C. Superior sulcus tumors: the role of imaging. J Thorac Imag 1989; 4: 41-48.
48. Rapoport S, Blair D, McCarthy S, Desser T, Hammers L, Sostman H. Brachial plexus: correlation of MR imaging with CT and pathologic findings. Radiology 1988; 167: 161-165.
49. Freundlich I, Chasen M, Datla G. Magnetic resonance imaging of pulmonary apical tumors. J Thorac Imag 1996; 11: 210-222.
50. Deschildre F, Petyt L, Rémy-Jardin M, Rémy J, Wannebroucq J. Evaluation de la TDM par balayage spirale volumique (BSV) vs IRM dans le bilan d'extension pariétal des masses thoraciques. Rev Im Med 1994; 6: 188.
51. Woodring JH. Determining the cause of pulmonary atelectasis: a comparison of plain radiography and CT. Am J Roentgenol 1988; 150: 757-763.
52. Rohlfing BM, White EA, Webb WR, Goodman PC. Hilar and mediastinal adenopathy caused by bacterial abscess of the lung. Radiology 1978; 128: 289-293.
53. Keogan MT, Tung KT, Kaplan DK, Goldstraw PJ, Hansell DM. The significance of pulmonary nodules detected on CT staging for lung cancer. Clin Radiol 1993; 48: 94-96.
54. Grover FL. The role of CT and MRI in staging of the mediastinum. Chest 1994; 106: 391S-396S.
55. Quint LE, Francis IR, Wahl RL, Gross BH, Glazer GM. Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. AJR 1995; 164: 1349-1359.
56. Webb WR, Golden JA. Imaging strategies in the staging of lung cancer. Clin Chest Med 1991; 12: 133-150.
57. Armstrong P, Vincent JM. Staging non-small cell lung cancer. Clin Radiol 1993; 48: 1-10.
58. Glazer GM, Gross BH, Quint LE, Francis IR, Bookstein FL, Orringer MB. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR 1985; 144: 261-265.
59. Ikezoe J, Kadowaki K, Morimoto S. Mediastinal lymph node metastases from non-small-cell bronchogenic carcinoma: re-evaluation with CT. J Comput Assist Tomogr 1990; 14: 340-344.
60. Dillemans B, Deneffe G, Verschakelen J, Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardiothorac Surg 1994; 8: 37-42.
61. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182: 319-323.
62. Dales R, Stark R, Raman S. Computed tomography to stage lung cancer. Am Rev Respir Dis 1990; 144: 1096-1101.
63. Quint L, Glazer G, Orringer M, Francis I, Bookstein F. Mediastinal lymph node detection and sizing azt CT and autopsy. AJR 1986; 147: 469-472.
64. Daly BJ, Faling L, Pugath R. Computed tomography. An effective technique for mediastinal staging in lung cancer. J Thorac Cardiovasc Surg 1984; 88: 486-494.
65. Becker GL, Whitlock WL, Schaefer PS, Tenholder MF. The impact of thoracic computed tomography in clinically staged T1 N0, MO chest lesions. Arch Intern Med 1990; 150: 557-559.
66. Parker LA, Mauro MA, Delany DJ. Evaluation of T1N0M0 lung cancer with CT. J Comput Assist Tomogr 1991; 15: 943-947.
67. Seely JM, Mayo JR, Miller RR, Müller NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993; 186: 129-132.
68. Gross B, Glazer G, Orringer M, Spizarny D, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance. Radiology 1988; 166: 71-74.
69. Arita T, Matsumoto T, Kuramitsu T, Kawamura N, Sugi K, Esato K. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. Chest 1996; 110: 1004-1008.
70. Buy JN, Ghossain MA, Poirson F, et al. Computed tomography of mediastinal lymph nodes in nonsmall-cell lung cancer. A new approach based on the lymphatic pathway of tumor spread. J Comput Assist Tomogr 1988; 12: 545-552.
71. Daly BD, Mueller JD, Faling LJ, et al. N2 lung cancer: outcome in patients with false-negative computed tomographics scans of the chest. J Thorac Cardiovasc Surg 1993; 105: 904-911.
72. Harrow EM, Abi-Saleh W, Blum J, et al. The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma. Am J Respir Crit Care Med 2000; 161: 601-607.
73. DeLeyn P, Schoonooghe P, Deneffe G, et al. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease). Eur J Cardiothorac Surg 1996; 10: 649-655.
74. Pearson F, DeLarue N, Ilves R, Todd T, Cooper J. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 1982; 83: 1-11.
75. Cybulsky I, Lanza L, Ryan M, Putman J, McMurtrey M, Roth J. Prognostic significance of computed tomography in resected N2 lung cancer. Ann Thorac Surg 1992; 54: 533-537.
76. Martini N, Kris MG, Flehinger BJ, et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: the Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55: 1365-1374.
77. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994 86: 673-680.
78. Taylor SI, Trybula M, Bonomi P. Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. Ann Thorac Surg 1987; 43: 87-91.
79. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 1994; 330: 153-158.
80. Vansteenkiste J, De Leyn P, Deneffe G, Menten J, Lerut T, Demedts M. Present status of induction treatment in stage IIIA-N2 non-small cell lung cancer: a review. Eur J Cardiothorac Surg 1998; 13: 1-12.
81. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Chest 1997; 112: 1480-1486.
82. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 1998; 16: 2142-2149.
83. Kernstine KH, Stanford W, Mullan BF, et al. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma. Ann Thorac Surg 1999; 68: 1022-1028.
84. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
85. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal nonsmall cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-377.
86. Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? Eur J Nucl Med 1998; 25: 1495-1501.
87. Sider L, Horejs D. Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT. AJR 1988; 151: 893-895.
88. Quint LE, Tummala S, Brisson LJ, et al. Distribution of distant metastases from newly diagnosed non-small cell lung cancer. Ann Thorac Surg 1996; 62: 246-250.
89. Salvatierra A, Baamonde C, Llamas JM, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma. Chest 1990; 97: 1052-1058.
90. Yeh HC, Rabinowitz JG. Ultrasonography and computed tomography of the liver. Radiol Clin North Am 1980; 18: 321-338.
91. Oliver TW, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in nonsmall cell bronchogenic carcinoma. Radiology 1984; 153: 217-218.
92. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996; 166: 531-536.
93. Korobkin M, Brodeur F, Francis I, Quint L, Dunnick N, Goodsitt M. Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 1996; 200: 737-742.
94. Korobkin M, Brodeur F, Francis I, Quint L, Dunnick N. CT time-attenuation washout curves of adrenal adenomas and non-adenomas. AJR 1998; 170: 747-752.
95. Schwartz LH, Panicek DM, Koutcher JA, et al. Adrenal masses in patients with malignancy: prospective comparison of echoplanar, fast spin-echo, and chemical shift MR imaging. Radiology 1995; 197: 421-425.
96. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995; 197: 411-418.
97. Yokoi K, Kamiya N, Matsuguma H, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 1999; 115: 714-719.
98. Tarver RD, Richmond BD, Klatte EC. Cerebral metastases from lung carcinoma: neurological and CT correlation. Work in progress. Radiology 1984; 153: 689-692.